IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
不乱下2019-04-25 11:27
$Interpace诊断(IDXG)$ 从事于美国甲状腺癌/胰腺癌组织LDT基因诊断服务(不是液体活检),这是一家LDT服务商。 IDXG的主要产品都是并购过来的资产,所以这家公司的定位就是一个商业化公司而不是一个技术公司。 按照公司的说法,公司在甲状腺癌组织基因诊断服务方面技术上还是领先的,而胰腺癌好像...查看全文
$Interpace诊断(IDXG)$ 8-K - Current report Filed: 2019-01-29 AccNo: 0001493152-19-001054 Size: 574 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits http...
$Interpace诊断(IDXG)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-01-28 AccNo: 0001493152-19-001046 Size: 1 MB 网页链接
$Interpace诊断(IDXG)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-01-25 AccNo: 0001493152-19-000930 Size: 1 MB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2018-12-11 AccNo: 0001493152-18-017345 Size: 111 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officer...
$Interpace Diagnostics Group, Inc.(IDXG)$ CORRESP [Cover] - Correspondence Filed: 2018-10-17 AccNo: 0001493152-18-014576 Size: 16 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ CORRESP [Cover] - Correspondence Filed: 2018-10-17 AccNo: 0001493152-18-014576 Size: 16 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-10-16 AccNo: 0000000000-18-032467 Size: 46 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-10-16 AccNo: 0000000000-18-032467 Size: 46 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-14 AccNo: 0001493152-18-016132 Size: 3 MB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2018-11-13 AccNo: 0001493152-18-015784 Size: 267 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接